相关产品推荐更多 >
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 询价记录
- 文献和实验
- 技术资料
- 免疫原:
Carrier-protein conjugated synthetic peptide encompassing a sequence within the N-terminus region of human LC3B. The exact sequence is proprietary.
- 亚型:
IgG
- 形态:
Liquid
- 保存条件:
Store as concentrated solution. Centrifuge briefly prior to opening vial. For short-term storage (1-2 weeks), store at 4ºC. For long-term storage, aliquot and store at -20ºC or below. Avoid multiple freeze-thaw cycles.
- 克隆性:
Polyclonal
- 标记物:
Unconjugated
- 适应物种:
Human, Mouse, Rat, Guinea pig, Pig, Mosquito
- 保质期:
12 months from the shipping date of the product.
- 抗原来源:
Human
- 目录编号:
GTX127375
- 级别:
Primary Antibodies
- 库存:
Available
- 供应商:
GeneTex
- 宿主:
Rabbit
- 应用范围:
WB, ICC/IF, IHC-P, IHC-Fr, FACS, IP
- 浓度:
0.14 mg/ml (Please refer to the vial label for the specific concentration.)
- 靶点:
Cross-reactivity may occur with other LC3 isoforms
- 抗体英文名:
LC3B antibody
- 抗体名:
LC3B 抗体
- 规格:
100 μl/25 μl
| 规格: | 100 μl | 产品价格: | ¥4000.0 |
|---|---|---|---|
| 规格: | 25 μl | 产品价格: | ¥1700.0 |
Wild-type (WT) and LC3B knockout (KO) 293T cell extracts (30 μg) were separated by 15% SDS-PAGE, and the membrane was blotted with LC3B antibody (GTX127375) diluted at 1:500. The HRP-conjugated anti-rabbit IgG antibody (GTX213110-01) was used to detect the primary antibody, and the signal was developed with Trident ECL plus-Enhanced.
LC3B antibody detects LC3B protein at autophagosome by immunofluorescent analysis.
Samples: HeLa cells mock (left) and treated with 50μM Chloroquine for 24 hr (right) were fixed in 4% PFA at RT for 15 min.
Green: LC3B protein stained by LC3B antibody (GTX127375) diluted at 1:2000.
Red: alpha Tubulin, a cytoskeleton marker, stained by alpha Tubulin antibody [GT114] (GTX628802) diluted at 1:1000.
Blue: Hoechst 33342 staining.
Untreated (–) and treated (+) HepG2 whole cell extracts (30 μg) were separated by 15% SDS-PAGE, and the membranes were blotted with LC3B antibody (GTX127375) diluted at 1:1000 and competitor's antibody (# Highly Cited Antibody ) diluted at 1:1000. The HRP-conjugated anti-rabbit IgG antibody (GTX213110-01) was used to detect the primary antibody.
*The competitor is not affiliated with GeneTex and does not endorse this product.
LC3B antibody detects MAP1LC3B protein by western blot analysis.
A. 20 μg Huh7 whole cell lysate/extract (untreated)
B. 20 μg Huh7 whole cell lysate/extract (3uM-Thapsigargin treatment for 12hr)
LC3B antibody (GTX127375) dilution: 1:1500
The HRP-conjugated anti-rabbit IgG antibody (GTX213110-01) was used to detect the primary antibody.
LC3B antibody detects LC3B protein at autophagosome by immunofluorescent analysis.
Sample: Mock and treated HeLa cells were fixed in 4% PFA at RT for 15 min.
Green: LC3B stained by LC3B antibody (GTX127375) diluted at 1:500.
Red: phalloidin, a cytoskeleton marker, diluted at 1:200.
Blue: Fluoroshield with DAPI (GTX30920).
Scale bar= 10 μm.
LC3B antibody detects MAP1LC3B protein by western blot analysis.
A. 50 μg Rat brain lysate/extract
15% SDS-PAGE
LC3B antibody (GTX127375) dilution: 1:1000
The HRP-conjugated anti-rabbit IgG antibody (GTX213110-01) was used to detect the primary antibody.
LC3B antibody (GTX127375) detects LC3B protein by flow cytometry analysis.
Sample: HeLa cell fixed in 4% PFA at 4oC for 5 min.
Brown: Unlabelled sample was also used as a control.
Blue: LC3B antibody (GTX127375) dilution: 1:100.
Acquisition of >20,000 events were collected using Argon ion laser (488nm) and 525/30 bandpass filter.
LC3B antibody detects LC3B protein at cytoplasm by immunohistochemical analysis.
Sample: Paraffin-embedded rat brain.
LC3B stained by LC3B antibody (GTX127375) diluted at 1:500.
Antigen Retrieval: Citrate buffer, pH 6.0, 15 min
Untreated (–) and treated (+) HepG2 whole cell extracts (30 μg) were separated by 15% SDS-PAGE, and the membrane was blotted with LC3B antibody (GTX127375) diluted at 1:1000. The HRP-conjugated anti-rabbit IgG antibody (GTX213110-01) was used to detect the primary antibody.
风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。
- 作者
- 内容
- 询问日期
文献和实验Mirra S et al., Neurobiol Dis 2021 (PMID:34048907)
Wang SH et al., J Exp Clin Cancer Res 2021 (PMID:33712045)
Chen CY et al., Sci Rep 2021 (PMID:33504864)
Jing Z et al., Cancer Med 2020 (PMID:32324343)
Wu CY et al., J Cell Mol Med 2020 (PMID:33135320)
Wu PS et al., Biomedicines 2020 (PMID:33207739)
Perrone F et al., J Control Release 2020 (PMID:33212117)
Wang J et al., Cancer Med 2020 (PMID:32780562)
Huang YY et al., BMC Vet Res 2020 (PMID:32532319)
Huang CY et al., Nutrients 2020 (PMID:32532087)
Mohapatra S et al., Cell Death Differ 2020 (PMID:32483382)
Takizawa M et al., Toxicol Lett 2020 (PMID:32439581)
Weng SC et al., Insect Mol Biol 2020 (PMID:32338421)
El-Derany MO et al., Biochem Pharmacol 2020 (PMID:32240652)
Xia M et al., Int Immunopharmacol 2020 (PMID:31931362)
Yi H et al., Molecules 2018 (PMID:29865221)
Viana GM et al., J Clin Med 2020 (PMID:32024172)
Lin MW et al., Neurotherapeutics 2019 (PMID:31823156)
Dapas B et al., Int J Pharm 2020 (PMID:31862491)
Lin MW et al., Antioxidants (Basel) 2019 (PMID:31906147)
Ho KH et al., Neurotherapeutics 2020 (PMID:31916238)
Huang FI et al., Front Oncol 2019 (PMID:31024851)
Chen JC et al., Biomolecules 2019 (PMID:31505885)
Wang J et al., Aging (Albany NY) 2019 (PMID:31409760)
Siew JJ et al., Nat Commun 2019 (PMID:31375685)
Liang Y et al., Toxicol In Vitro 2019 (PMID:31648047)
Yan L et al., Lab Invest 2019 (PMID:31558773)
Chang L et al., Am J Cancer Res 2019 (PMID:31598395)
Homma T et al., Exp Cell Res 2019 (PMID:31479686)
Tedeschi V et al., Sci Rep 2019 (PMID:31341250)
Wong CW et al., J Med Chem 2019 (PMID:31361134)
Hsieh CC et al., Br J Pharmacol 2019 (PMID:31265743)
Izumi H et al., Sci Rep 2019 (PMID:30783186)
Hsu HL et al., Int J Mol Sci 2019 (PMID:30609861)
Lu LH et al., J Infect 2019 (PMID:30653985)
Lai HH et al., Biochem Biophys Res Commun 2018 (PMID:30336979)
Wu YW et al., Cell Death Discov 2018 (PMID:30245856)
Lin YC et al., J Ocul Pharmacol Ther 2018 (PMID:30020815)
Koh EH et al., Diabetes 2018 (PMID:30002134)
Lai YC et al., Antiviral Res 2018 (PMID:29752950)
Russo Spena C et al., J Control Release 2018 (PMID:29746956)
Huang YJ et al., ACS Appl Mater Interfaces 2018 (PMID:29775050)
Matsuo T et al., Biochem Biophys Res Commun 2018 (PMID:29421654)
Tsai CY et al., Int J Mol Sci 2017 (PMID:29267216)
Yu Y et al., Biochem Biophys Res Commun 2018 (PMID:29183728)
Chen CH et al., Clin Cancer Res 2017 (PMID:29222162)
Zhang Y et al., Am J Physiol Regul Integr Comp Physiol 2017 (PMID:28931544)
Laggner M et al., PLoS One 2017 (PMID:28700649)
Li TY et al., Biomed Pharmacother 2017 (PMID:28641163)
Su YC et al., J Tradit Complement Med 2012 (PMID:24716146)
Yen JH et al., Int J Mol Sci 2017 (PMID:28420170)
Lin S et al., Int J Biochem Cell Biol 2017 (PMID:28392376)
Tsai CH et al., Sci Rep 2017 (PMID:28195146)
Yang CM et al., Biores Open Access 2015 (PMID:26309785)
Chen PH et al., PLoS One 2016 (PMID:27893811)
Wild F et al., Autophagy 2016 (PMID:27715385)
Li H et al., Appl. Mater. Interfaces 2016 (Epub)
Hsieh YY et al., Am J Cancer Res 2016 (PMID:27648357)
Tsai WT et al., J Biol Chem 2016 (PMID:27458013)
Chen HR et al., PLoS Negl Trop Dis 2016 (PMID:27409803)
Sullivan PM et al., Acta Neuropathol Commun 2016 (PMID:27193190)
Chen KC et al., Cancer Genomics Proteomics 2016 (PMID:27107064)
Hsieh YY et al., Cell Death Discovery 2016 2()
Yao-Yu H et al., Oncotarget 2016 (PMID:27036028)
Wu PS et al., PLoS One 2015 (PMID:26087007)
Huang YJ et al., Nanoscale 2015 (PMID:26602242)
Hung SY et al., Neuropharmacology 2015 (PMID:25686800)
Liu BH et al., Biores Open Access 2013 (PMID:23514754)
Liu TP et al., Anticancer Drugs 2015 (PMID:25203626)
Lee KH et al., Sci Rep 2014 (PMID:25227736)
Hwang TI et al., Int J Oncol 2023 (PMID:37083075)
Wen Y et al., Vet Res 2022 (PMID:35927699)
Han YJ et al., J Biomed Sci 2023 (PMID:36737756)
Sapienza S et al., Int J Mol Sci 2022 (PMID:36361823)
Cardile A et al., Int J Mol Sci 2023 (PMID:36674794)
Li J et al., iScience 2023 (PMID:36636350)
Rong Chen et al., Clin Cosmet Investig Dermatol 2022 (PMID:35450398)
Kuo-Hao Ho et al., Neurotherapeutics 2021 (PMID:33410111)
Chiang-Wen Lee et al., Molecules 2022 (PMID:35056691)
Li-Li Wen et al., PLoS One 2021 (PMID:33471797)
Wataru Otsu et al., Sci Rep 2021 (PMID:34535730)
Wen-Jui Lee et al., Molecules 2021 (PMID:34770956)
Wang LC et al., Front Aging Neurosci 2021 (PMID:34867274)
Pitsch M et al., Cells 2021 (PMID:35011658)
Watanabe M et al., Molecules 2021 (PMID:35011407)
Tsai ML et al., Int J Mol Sci 2021 (PMID:35008429)
Lin TE et al., J Enzyme Inhib Med Chem 2022 (PMID:34894949)
Lee CW et al., Molecules 2022;27(2)
Liu Y et al., Technol Cancer Res Treat 2021 (PMID:34657484)
Beak JY et al., J Biol Chem 2021 (PMID:34756888)
Generation of Antibody Molecules Through Antibody Engineering
been overcome to a large extent using genetic-engineering techniques to produce chimeric mouse/human and completely human antibodies. Such an approach is particularly suitable because of the domain structure of the antibody molecule ( 2 ), where functional
The importance of antibody molecules was first recognized in the 1890s, when it was shown that immunity to tetanus and diphtheria was caused by antibodies against the bacterial exotoxins (1 ). Around the same time, it was shown that antisera
General comments: Antibodies, like most proteins, do not like to be freeze-thawed. Avoid repetitive freezing of your solution. The best way to store your antibody is to keep a high protein concentration (>1 mg/ml), add some protease
技术资料暂无技术资料 索取技术资料





![OLIG2 antibody [1G11]](https://img1.dxycdn.com/2022/0328/639/1026323767682500453-14.jpg!wh200)
![Alkaline phosphatase (intestinal) antibody [3B10E7]](https://img1.dxycdn.com/2022/0328/429/9419786266733500453-14.jpg!wh200)
![SUMO1 antibody [SUMO1/1188]](https://img1.dxycdn.com/2022/0328/299/6275616446911700453-14.jpg!wh200)
![FBL4 antibody [C1C3]](https://img1.dxycdn.com/2022/0328/961/4594536734441300453-14.jpg!wh200)

